TuSimple Holdings Inc.
TuSimple Holdings Inc. (TSPH) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for TuSimple Holdings Inc. (TSPH), covering cash flow, earnings, and balance sheets.
TuSimple Holdings Inc. (TSPH) Income Statement & Financial Overview
View the income breakdown for TuSimple Holdings Inc. TSPH across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $789000.00 | $381000.00 | $879000.00 | $1.21M |
| Gross Profit | -$789000.00 | -$381000.00 | -$879000.00 | -$1.21M |
| Gross Profit Ratio | ||||
| R&D Expenses | $39.29M | $10.60M | $16.59M | $19.21M |
| SG&A Expenses | $5.91M | $194.36M | $16.65M | $20.06M |
| Operating Expenses | $45.20M | $204.96M | $33.24M | $39.27M |
| Total Costs & Expenses | -$45.99M | -$205.34M | -$34.12M | -$40.48M |
| Interest Income | $4.17M | $5.89M | $7.65M | $8.05M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $789000.00 | $381000.00 | $879000.00 | $1.21M |
| EBITDA | -$60.88M | -$201.11M | -$36.58M | -$52.36M |
| EBITDA Ratio | ||||
| Operating Income | -$45.99M | -$205.34M | -$34.12M | -$40.48M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$15.67M | $3.85M | -$3.34M | -$13.09M |
| Income Before Tax | -$61.66M | -$201.49M | -$37.46M | -$53.57M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$61.77M | -$201.30M | -$37.46M | -$53.57M |
| Net Income Ratio | ||||
| EPS | -$0.27 | -$0.86 | -$0.16 | -$0.23 |
| Diluted EPS | -$0.27 | -$0.86 | -$0.16 | -$0.23 |
| Weighted Avg Shares Outstanding | $232.62M | $234.45M | $234.36M | $232.26M |
| Weighted Avg Shares Outstanding (Diluted) | $232.62M | $234.45M | $234.36M | $232.26M |
Over the past four quarters, TuSimple Holdings Inc. demonstrated steady revenue growth, increasing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Operating income reached -$45.99M in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$60.88M, reflecting operational efficiency. Net income rose to -$61.77M, with EPS at -$0.27. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan